NUE
50
3
WDC
49
-3
LH
55
2
APD
42
-2
PG
51
-2
WU
16
2
D
55
-6
AVY
54
-14
TXT
58
-2
SPG
53
-2
AEP
59
-3
AMT
58
-2
ADSK
65
-2
BF.B
57
7
MCD
63
-4
HRL
38
2
SBUX
41
-3
KMI
59
2
NWL
32
-3
PAYX
53
-4
NUE
50
3
WDC
49
-3
LH
55
2
APD
42
-2
PG
51
-2
WU
16
2
D
55
-6
AVY
54
-14
TXT
58
-2
SPG
53
-2
AEP
59
-3
AMT
58
-2
ADSK
65
-2
BF.B
57
7
MCD
63
-4
HRL
38
2
SBUX
41
-3
KMI
59
2
NWL
32
-3
PAYX
53
-4
Financhill
Back

Caribou Biosciences 10K Form

Buy
52

CRBU
Caribou Biosciences

Last Price:
2.08
Seasonality Move:
-20.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRBU News And Ratings

See the #1 stock for the next 7 days that we like better than CRBU

CRBU Financial Statistics

Sales & Book Value

Annual Sales: $34.48M
Cash Flow: $-35.23M
Price / Cash Flow: 0
Annual Sales: $3.44
Price / Book: 0.61

Profitability

EPS (TTM): -1.40000
Net Income (TTM): $-123.44M
Gross Margin: --
Return on Equity: -36.52%
Return on Assets: -30.57%

Caribou Biosciences Earnings Forecast

Key Caribou Biosciences Financial Ratios

  • The Research & Development expenses have been 325.07% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of CRBU is -296.05% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Caribou Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CRBU
Website: cariboubio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 8.75
Quick Ratio: 8.55

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRBU Technical Analysis vs Fundamental Analysis

Buy
52
Caribou Biosciences (CRBU) is a Buy

Is Caribou Biosciences a Buy or a Sell?